Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Kite Pharma Company Profile (NASDAQ:KITE)

Consensus Ratings for Kite Pharma (NASDAQ:KITE) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $49.84 (5.73% downside)

Analysts' Ratings History for Kite Pharma (NASDAQ:KITE)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/15/2014Stifel NicolausBoost Price TargetBuy$45.00 -> $71.00ViewTweet This Rating  Share This Rating on StockTwits
11/17/2014Jefferies GroupBoost Price TargetBuy$35.00 -> $46.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2014Canaccord GenuityReiterated RatingBuy$42.00 -> $51.00ViewTweet This Rating  Share This Rating on StockTwits
10/28/2014Canaccord GenuityInitiated CoverageBuy$42.00ViewTweet This Rating  Share This Rating on StockTwits
10/21/2014Stifel NicolausBoost Price TargetBuy$31.00 -> $45.00ViewTweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$73.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014Stifel NicolausInitiated CoverageBuy$31.00ViewTweet This Rating  Share This Rating on StockTwits
7/15/2014Citigroup Inc.Initiated CoverageBuy -> Outperform$31.00 -> $24.05ViewTweet This Rating  Share This Rating on StockTwits
7/15/2014Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
7/15/2014Credit SuisseInitiated CoverageOutperform$34.00ViewTweet This Rating  Share This Rating on StockTwits
7/15/2014Jefferies GroupInitiated CoverageBuy$35.00ViewTweet This Rating  Share This Rating on StockTwits
7/15/2014Stifel NicolausInitiated CoverageBuy$31.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/17/2012 forward)